FAQ > Glossary of Terms > C Series > CFR (Code For Federal Regulation)

A Series , B Series , C Series , D Series , E Series , F Series , G Series , H Series , I Series , K Series , L Series , M Series , N Series , O Series , P Series , Q Series , R Series , S Series , T Series , U Series , V Series , W Series , X Series , Y Series , Z Series

Calcium, Calcium Carbonate Equivalent, Calibration, Calibration(ICH API Definition), Calorie, Calorimetry, Cancer, Capsid, Carbohydrates, Carbon Filter, Carbon Thickness, Carbonate Hardness, Carcinogen, Carrier, Catabolism, Catalase, Catalyst, Cation, Cation Exchange, Cation Exchange Resin, Cavitation, Centre for Biologics Evaluation and Research(CBER), Centre for Drug Evaluation and Research(CDER), Certified Vendor Drawings, Celsius, Cell, Cell Bank, Cell Culture, Cell Differentiation, Cell Fusion ,Cell Lines, Cellulose, Centimorgan(cM), Centrifugation, Centrifuge, Sedimenters, Centromere, Certification, CFR(Code of Federal Regulation), CFU(Colony Forming Unit), cGMPs(Current Good Manufacturing Practices), Change Control, Change Over, Channeling, Characterization, Checksum, Chelating Agents, Chemoautotrophs, Chemostat, Chemotheraphy, Chimeric, Chloramine, Chlorinated Vinyls, Chlorination, Chlorine, Chlorine Demand, Chlorine Residual, Chloroplasts, CHO(Chinese Hamster Ovary) Cells, Chromatids, Next 60 - 120 Words, Next 120 - 175 Words

Learn About Deadly Cancer Mesothelioma due to Asbestos Exposure, it can affect any one in the world

CFR (Code of Federal regulations) Title 21
The U.S. regulations that directly apply to biopharmaceutical development are contained in Title 21 parts 58 (Good Laboratory Practice for Nonclinical Laboratory Studies), 210 (Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General), 211 (Current Good Manufacturing Practice for Finished Pharmaceuticals), and 600 (Biological Products: General).
Parts 50 (Protection of Human Subjects), 56 (Institutional Review Boards), and 312 (Investigational New Drugs) apply to critical trials.
Part 11 provides criteria which will consider electronic records to be equivalent to paper records and electronic signatures to be equivalent to traditional handwritten signatures. (also see: cGMPs (current Good Manufacturing Practices))